Virology2014; 462-463; 388-403; doi: 10.1016/j.virol.2014.04.029

Experiences with infectious cDNA clones of equine arteritis virus: lessons learned and insights gained.

Abstract: The advent of recombinant DNA technology, development of infectious cDNA clones of RNA viruses, and reverse genetic technologies have revolutionized how viruses are studied. Genetic manipulation of full-length cDNA clones has become an especially important and widely used tool to study the biology, pathogenesis, and virulence determinants of both positive and negative stranded RNA viruses. The first full-length infectious cDNA clone of equine arteritis virus (EAV) was developed in 1996 and was also the first full-length infectious cDNA clone constructed from a member of the order Nidovirales. This clone was extensively used to characterize the molecular biology of EAV and other Nidoviruses. The objective of this review is to summarize the characterization of the virulence (or attenuation) phenotype of the recombinant viruses derived from several infectious cDNA clones of EAV in horses, as well as their application for characterization of the molecular basis of viral neutralization, persistence, and cellular tropism.
Publication Date: 2014-06-07 PubMed ID: 24913633PubMed Central: PMC7172799DOI: 10.1016/j.virol.2014.04.029Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article presents a comprehensive review of the various studies conducted on equine arteritis virus (EAV) using infectious cDNA clone technology. The study includes the applications of this technology in checking viral neutralization, persistence, and cellular tropism, along with examining the virulence of recombinant viruses derived from EAV clones.

Understanding Infectious cDNA Clones of RNA Viruses

  • The article focuses on the utilization of recombinant DNA technology, infectious cDNA clones (clones containing the entire genetic material of a virus) of RNA viruses, and reverse genetic technologies. These advanced methodologies have significantly transformed the way viruses are investigated.
  • Genetic manipulation of full-length cDNA clones has emerged as a crucially important tool in studying the biology, pathogenesis, and factors determining the virulence of both positive and negative stranded RNA viruses.

The First Infectious cDNA Clone of Equine Arteritis Virus (EAV)

  • The first full-length infectious cDNA clone of equine arteritis virus (EAV) was developed in 1996. This clone was unique as it was the first full-length infectious cDNA clone developed from a member of the order Nidovirales.
  • This clone was widely used to explore the molecular biology of EAV and other Nidoviruses. Understanding the virus at a molecular level aids in crafting efficient treatment strategies.

Characterizing Virulence and Attenuation Phenotypes of EAV

  • The review summarizes the characterization of the virulence (or attenuation) phenotype of the recombinant viruses derived from several infectious cDNA clones of EAV in horses.
  • These findings are essential to understand how the virus behaves and how its virulence changes when it infects a host organism. This knowledge could be crucial in predicting the severity of outbreaks and in developing effective vaccinations or treatments.

Molecular Basis of Viral Neutralization, Persistence, and Cellular Tropism

  • Besides the study of virulence, the infectious cDNA clones of EAV were also used to explore the molecular basis of viral neutralization, persistence, and cellular tropism.
  • Viral neutralization is the mechanism by which a virus is rendered non-infectious. Persistence refers to the ability of a virus to remain in a host for long periods, while cellular tropism concerns the preference of a virus to infect specific cell types.
  • The understanding of these aspects is critical for research into virus-host interactions, as well as for designing appropriate therapeutic interventions.

Cite This Article

APA
Balasuriya UB, Zhang J, Go YY, MacLachlan NJ. (2014). Experiences with infectious cDNA clones of equine arteritis virus: lessons learned and insights gained. Virology, 462-463, 388-403. https://doi.org/10.1016/j.virol.2014.04.029

Publication

ISSN: 1096-0341
NlmUniqueID: 0110674
Country: United States
Language: English
Volume: 462-463
Pages: 388-403
PII: S0042-6822(14)00152-4

Researcher Affiliations

Balasuriya, Udeni B R
  • 108 Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA. Electronic address: ubalasuriya@uky.edu.
Zhang, Jianqiang
  • Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA.
Go, Yun Young
  • Virus Research and Testing Group, Division of Drug Discovery Research, Korea Research Institute of Chemical Technology, Daejeon 305-343, South Korea.
MacLachlan, N James
  • Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

MeSH Terms

  • Animals
  • Cloning, Molecular
  • DNA, Complementary / genetics
  • Equartevirus / genetics
  • Equartevirus / pathogenicity
  • Equartevirus / physiology
  • Horses
  • Reverse Genetics
  • Virulence

References

This article includes 113 references
  1. ALEXANDER HE, KOCH G, MOUNTAIN IM, SPRUNT K, VAN DAMME O. Infectivity of ribonucleic acid of poliovirus on HeLa cell mono-layers.. Virology 1958 Feb;5(1):172-3.
    pubmed: 13519758doi: 10.1016/0042-6822(58)90014-xgoogle scholar: lookup
  2. ALEXANDER HE, KOCH G, MOUNTAIN IM, VAN DAMME O. Infectivity of ribonucleic acid from poliovirus in human cell monolayers.. J Exp Med 1958 Oct 1;108(4):493-506.
    pmc: PMC2136898pubmed: 13575680doi: 10.1084/jem.108.4.493google scholar: lookup
  3. Balasuriya UB, Dobbe JC, Heidner HW, Smalley VL, Navarrette A, Snijder EJ, MacLachlan NJ. Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone.. Virology 2004 Apr 10;321(2):235-46.
    pubmed: 15051384doi: 10.1016/j.virol.2003.12.015google scholar: lookup
  4. Balasuriya UB, Evermann JF, Hedges JF, McKeirnan AJ, Mitten JQ, Beyer JC, McCollum WH, Timoney PJ, MacLachlan NJ. Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus.. J Am Vet Med Assoc 1998 Dec 1;213(11):1586-9, 1570.
    pubmed: 9838958
  5. Balasuriya UB, Go YY, MacLachlan NJ. Equine arteritis virus.. Vet Microbiol 2013 Nov 29;167(1-2):93-122.
  6. Balasuriya UBR, Hedges JF, Nadler SA, McCollum WH, Timoney PJ, MacLachlan NJ. Genetic stability of equine arteritis virus during horizontal and vertical transmission in an outbreak of equine viral arteritis.. J Gen Virol 1999 Aug;80 ( Pt 8):1949-1958.
    pubmed: 10466790doi: 10.1099/0022-1317-80-8-1949google scholar: lookup
  7. Balasuriya UBR, Hedges JF, Smalley VL, Navarrette A, McCollum WH, Timoney PJ, Snijder EJ, MacLachlan NJ. Genetic characterization of equine arteritis virus during persistent infection of stallions.. J Gen Virol 2004 Feb;85(Pt 2):379-390.
    pubmed: 14769895doi: 10.1099/vir.0.19545-0google scholar: lookup
  8. Balasuriya UB, Heidner HW, Davis NL, Wagner HM, Hullinger PJ, Hedges JF, Williams JC, Johnston RE, David Wilson W, Liu IK, James MacLachlan N. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses.. Vaccine 2002 Feb 22;20(11-12):1609-17.
    pubmed: 11858869doi: 10.1016/s0264-410x(01)00485-6google scholar: lookup
  9. Balasuriya UB, MacLachlan NJ. The immune response to equine arteritis virus: potential lessons for other arteriviruses.. Vet Immunol Immunopathol 2004 Dec 8;102(3):107-29.
    pubmed: 15507299doi: 10.1016/j.vetimm.2004.09.003google scholar: lookup
  10. Balasuriya UB, Maclachlan NJ, De Vries AA, Rossitto PV, Rottier PJ. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus.. Virology 1995 Mar 10;207(2):518-27.
    pubmed: 7533965doi: 10.1006/viro.1995.1112google scholar: lookup
  11. Balasuriya UB, Patton JF, Rossitto PV, Timoney PJ, McCollum WH, MacLachlan NJ. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.. Virology 1997 May 26;232(1):114-28.
    pubmed: 9185595doi: 10.1006/viro.1997.8551google scholar: lookup
  12. Balasuriya U.B., Snijder E.J. Arterivirus. In: Mettenleiter T.C., Sobrino F., editors. Animal Viruses: Molecular Biology. Caister Academic Press; Norwich, United Kingdom: 2008. pp. 97u2013148.
  13. Balasuriya UBR, Snijder EJ, Heidner HW, Zhang J, Zevenhoven-Dobbe JC, Boone JD, McCollum WH, Timoney PJ, MacLachlan NJ. Development and characterization of an infectious cDNA clone of the virulent Bucyrus strain of Equine arteritis virus.. J Gen Virol 2007 Mar;88(Pt 3):918-924.
    pubmed: 17325365doi: 10.1099/vir.0.82415-0google scholar: lookup
  14. Balasuriya UB, Snijder EJ, van Dinten LC, Heidner HW, Wilson WD, Hedges JF, Hullinger PJ, MacLachlan NJ. Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions.. Virology 1999 Jul 20;260(1):201-8.
    pubmed: 10405372doi: 10.1006/viro.1999.9817google scholar: lookup
  15. Balasuriya, U.B.R., Snijder, E.J., MacLachlan, N.J., 2000. Phenotypic characterization of equine arteritis virus with an infectious cDNA clone. Unpublished data.
  16. Boyer JC, Haenni AL. Infectious transcripts and cDNA clones of RNA viruses.. Virology 1994 Feb;198(2):415-26.
    pubmed: 8291226doi: 10.1006/viro.1994.1053google scholar: lookup
  17. Castillo-Olivares J, Wieringa R, Bakonyi T, de Vries AA, Davis-Poynter NJ, Rottier PJ. Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.. J Virol 2003 Aug;77(15):8470-80.
  18. Chen Z, Li K, Plagemann PG. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.. Virology 2000 Jan 5;266(1):88-98.
    pubmed: 10612663doi: 10.1006/viro.1999.0050google scholar: lookup
  19. Chirnside ED, Francis PM, de Vries AA, Sinclair R, Mumford JA. Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus.. J Virol Methods 1995 Jul;54(1):1-13.
    pmc: PMC7119792pubmed: 7559853doi: 10.1016/0166-0934(95)00020-ugoogle scholar: lookup
  20. Deregt D, de Vries AA, Raamsman MJ, Elmgren LD, Rottier PJ. Monoclonal antibodies to equine arteritis virus proteins identify the GL protein as a target for virus neutralization.. J Gen Virol 1994 Sep;75 ( Pt 9):2439-44.
    pubmed: 8077945doi: 10.1099/0022-1317-75-9-2439google scholar: lookup
  21. Dobbe JC, van der Meer Y, Spaan WJ, Snijder EJ. Construction of chimeric arteriviruses reveals that the ectodomain of the major glycoprotein is not the main determinant of equine arteritis virus tropism in cell culture.. Virology 2001 Sep 30;288(2):283-94.
    pubmed: 11601900doi: 10.1006/viro.2001.1074google scholar: lookup
  22. Das PB, Vu HL, Dinh PX, Cooney JL, Kwon B, Osorio FA, Pattnaik AK. Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response.. Virology 2011 Feb 20;410(2):385-94.
    pubmed: 21195444doi: 10.1016/j.virol.2010.12.002google scholar: lookup
  23. de Vries AA, Glaser AL, Raamsman MJ, de Haan CA, Sarnataro S, Godeke GJ, Rottier PJ. Genetic manipulation of equine arteritis virus using full-length cDNA clones: separation of overlapping genes and expression of a foreign epitope.. Virology 2000 Apr 25;270(1):84-97.
    pubmed: 10772982doi: 10.1006/viro.2000.0245google scholar: lookup
  24. de Vries AA, Glaser AL, Raamsman MJ, Rottier PJ. Recombinant equine arteritis virus as an expression vector.. Virology 2001 Jun 5;284(2):259-76.
    pubmed: 11384225doi: 10.1006/viro.2001.0908google scholar: lookup
  25. Del Piero F. Equine viral arteritis.. Vet Pathol 2000 Jul;37(4):287-96.
    pubmed: 10896389doi: 10.1354/vp.37-4-287google scholar: lookup
  26. den Boon JA, Faaberg KS, Meulenberg JJ, Wassenaar AL, Plagemann PG, Gorbalenya AE, Snijder EJ. Processing and evolution of the N-terminal region of the arterivirus replicase ORF1a protein: identification of two papainlike cysteine proteases.. J Virol 1995 Jul;69(7):4500-5.
  27. den Boon JA, Snijder EJ, Chirnside ED, de Vries AA, Horzinek MC, Spaan WJ. Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily.. J Virol 1991 Jun;65(6):2910-20.
  28. Den Boon JA, Snijder EJ, Locker JK, Horzinek MC, Rottier PJ. Another triple-spanning envelope protein among intracellularly budding RNA viruses: the torovirus E protein.. Virology 1991 Jun;182(2):655-63.
    pmc: PMC7130535pubmed: 2024492doi: 10.1016/0042-6822(91)90606-cgoogle scholar: lookup
  29. BRYANS JT, CROWE ME, DOLL ER, MCCOLLUM WH. Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus.. Cornell Vet 1957 Jan;47(1):3-41.
    pubmed: 13397177
  30. Doll ER, Bryans JT, Wilson JC, McCollum WH. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney.. Cornell Vet 1968 Oct;48(4):497-524.
    pubmed: 4971878
  31. BRYANS JT, DOLL ER, KNAPPENBERGER RE. An outbreak of abortion caused by the equine arteritis virus.. Cornell Vet 1957 Jan;47(1):69-75.
    pubmed: 13397180
  32. Dunowska M, Biggs PJ, Zheng T, Perrott MR. Identification of a novel nidovirus associated with a neurological disease of the Australian brushtail possum (Trichosurus vulpecula).. Vet Microbiol 2012 May 4;156(3-4):418-24.
  33. Firth AE, Zevenhoven-Dobbe JC, Wills NM, Go YY, Balasuriya UBR, Atkins JF, Snijder EJ, Posthuma CC. Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production.. J Gen Virol 2011 May;92(Pt 5):1097-1106.
    pmc: PMC3139419pubmed: 21307223doi: 10.1099/vir.0.029264-0google scholar: lookup
  34. Fukunaga Y, McCollum WH. Complement-fixation reactions in equine viral arteritis.. Am J Vet Res 1977 Dec;38(12):2043-6.
    pubmed: 202179
  35. Glaser AL, de Vries AA, Dubovi EJ. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.. J Gen Virol 1995 Sep;76 ( Pt 9):2223-33.
    pubmed: 7561759doi: 10.1099/0022-1317-76-9-2223google scholar: lookup
  36. Glaser A., de Vries A.A.F., Raamsman M.J.B., Horzinek M.C., Rottier P.J.M. An infectious cDNA clone of equine arteritis virus: a tool for future fundamental studies and vaccine development. In: Wernery U., Wade J.F., Mumford J.A., Kaaden O.R., editors. Proceeding of the Eigth Equine Infectious Disease. R & W Publications (Newmarket) Ltd.; Dubai: 1999. pp. 166u2013176.
  37. Go YY, Bailey E, Cook DG, Coleman SJ, Macleod JN, Chen KC, Timoney PJ, Balasuriya UB. Genome-wide association study among four horse breeds identifies a common haplotype associated with in vitro CD3+ T cell susceptibility/resistance to equine arteritis virus infection.. J Virol 2011 Dec;85(24):13174-84.
    pmc: PMC3233183pubmed: 21994447doi: 10.1128/JVI.06068-11google scholar: lookup
  38. Go YY, Bailey E, Timoney PJ, Shuck KM, Balasuriya UB. Evidence that in vitro susceptibility of CD3+ T lymphocytes to equine arteritis virus infection reflects genetic predisposition of naturally infected stallions to become carriers of the virus.. J Virol 2012 Nov;86(22):12407-10.
    pmc: PMC3486460pubmed: 22933293doi: 10.1128/JVI.01698-12google scholar: lookup
  39. Go YY, Cook RF, Fulgu00eancio JQ, Campos JR, Henney P, Timoney PJ, Horohov DW, Balasuriya UB. Assessment of correlation between in vitro CD3+ T cell susceptibility to EAV infection and clinical outcome following experimental infection.. Vet Microbiol 2012 May 25;157(1-2):220-5.
    pubmed: 22177968doi: 10.1016/j.vetmic.2011.11.031google scholar: lookup
  40. Go YY, Zhang J, Timoney PJ, Cook RF, Horohov DW, Balasuriya UB. Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes.. J Virol 2010 May;84(10):4898-911.
    pmc: PMC2863813pubmed: 20219931doi: 10.1128/JVI.02743-09google scholar: lookup
  41. Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. Nidovirales: evolving the largest RNA virus genome.. Virus Res 2006 Apr;117(1):17-37.
  42. Harry TO, McCollum WH. Stability of viability and immunizing potency of lyophilized, modified equine arteritis live-virus vaccine.. Am J Vet Res 1981 Sep;42(9):1501-5.
    pubmed: 6275755
  43. Hedges JF, Balasuriya UB, Timoney PJ, McCollum WH, MacLachlan NJ. Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions.. J Virol 1999 May;73(5):3672-81.
  44. Hedges JF, Demaula CD, Moore BD, McLaughlin BE, Simon SI, MacLachlan NJ. Characterization of equine E-selectin.. Immunology 2001 Aug;103(4):498-504.
  45. Hyllseth B. A plaque assay of equine arteritis virus in BHK-21 cells.. Arch Gesamte Virusforsch 1969;28(1):26-33.
    pubmed: 4988871doi: 10.1007/BF01250842google scholar: lookup
  46. BRYANS JT, DOLL ER, JONES TC. The lesions of equine viral arteritis.. Cornell Vet 1957 Jan;47(1):52-68.
    pubmed: 13397179
  47. Konishi S, Akashi H, Sentsui H, Ogata M. Studies on equine viral arteritis. I. Characterization of the virus and trial survey on antibody with vero cell cultures.. Nihon Juigaku Zasshi 1975 Oct;37(5):259-67.
    pubmed: 172689doi: 10.1292/jvms1939.37.5_259google scholar: lookup
  48. Kroese MV, Zevenhoven-Dobbe JC, Bos-de Ruijter JNA, Peeters BPH, Meulenberg JJM, Cornelissen LAHM, Snijder EJ. The nsp1alpha and nsp1 papain-like autoproteinases are essential for porcine reproductive and respiratory syndrome virus RNA synthesis.. J Gen Virol 2008 Feb;89(Pt 2):494-499.
    pubmed: 18198380doi: 10.1099/vir.0.83253-0google scholar: lookup
  49. Lu Z, Zhang J, Huang CM, Go YY, Faaberg KS, Rowland RR, Timoney PJ, Balasuriya UB. Chimeric viruses containing the N-terminal ectodomains of GP5 and M proteins of porcine reproductive and respiratory syndrome virus do not change the cellular tropism of equine arteritis virus.. Virology 2012 Oct 10;432(1):99-109.
    pubmed: 22739441doi: 10.1016/j.virol.2012.05.022google scholar: lookup
  50. MacLachlan NJ, Balasuriya UB. Equine viral arteritis.. Adv Exp Med Biol 2006;581:429-33.
  51. MacLachlan NJ, Balasuriya UB, Rossitto PV, Hullinger PA, Patton JF, Wilson WD. Fatal experimental equine arteritis virus infection of a pregnant mare: immunohistochemical staining of viral antigens.. J Vet Diagn Invest 1996 Jul;8(3):367-74.
    pubmed: 8844583doi: 10.1177/104063879600800316google scholar: lookup
  52. Maess J, Reczko E, Bu00f6hm HO. [Equine arteritis virus: multiplication in BHK 21-cells buoyant density and electron microscopical demonstration].. Arch Gesamte Virusforsch 1970;30(1):47-58.
    pubmed: 4194811
  53. McCollum, W.H., 1970a. Vaccination for equine viral arteritis. In: Bryans, J.T., Gerber, H. (Eds.), Proceedings of the Second International Conference on Equine Infectious Diseases. S. Karger, Basel, Paris, pp. 143u2013151.
  54. McCollum WH. Development of a modified virus strain and vaccine for equine viral arteritis.. J Am Vet Med Assoc 1969 Jul 15;155(2):318-22.
    pubmed: 4978804
  55. McCollum, W.H., 1970b. Vaccination for equine viral arteritis. In: Bryans, J.T., Gerber, H. (Eds.), Proceedings of the Second International Conference on Equine Infectious Diseases, Paris 1969. S. Karger, Basel, pp. 143u2013151.
  56. McCollum W.H., Doll E.R., Wilson J.C., Cheatham J. Isolation and propagation of equine arteritis virus in monolayer cell cultures of rabbit kidney. Cornell Vet. 1962;52:452u2013458.
  57. McCollum W.H., Doll E.R., Wilson J.C. The recovery of virus from horses with experimental cases of equine artertis using monolayer cell cultures of rabbit kidney. Am. J. Vet. Res. 1961;23:465u2013469.
  58. McCollum W.H., Doll E.R., Wilson J.C., Johnson C.B. Propagation of equine arteritis virus in monolayer cultures of equine kidney. Am. J. Vet. Res. 1961;22:731u2013735.
  59. McCollum, W.H., Timoney, P.J., 1999. Experimental observations on the virulence of isolates of equine arteritis virus. In: Wernery, U., Wade, J.F., Mumford, J.A., Kaaden, O.R. (Eds.), Proceedings of the Eigth International Conference Equine Infectious Diseases. R & W Publications (Newmarket) Limited, Dubai, pp. 558u2013559.
  60. McKinnon A.O., Colbern G.T., Collins J.K., Bowen R.A., Voss J.L., Umphenour J.W. Vaccination of stallions with a modified live equine arteritis virus vaccine. J. Equine Vet. Sci. 1986;6:66u201369.
  61. Meulenberg JJ, Hulst MM, de Meijer EJ, Moonen PL, den Besten A, de Kluyver EP, Wensvoort G, Moormann RJ. Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV.. Virology 1993 Jan;192(1):62-72.
    pmc: PMC7173055pubmed: 8517032doi: 10.1006/viro.1993.1008google scholar: lookup
  62. Miszczak F, Legrand L, Balasuriya UB, Ferry-Abitbol B, Zhang J, Hans A, Fortier G, Pronost S, Vabret A. Emergence of novel equine arteritis virus (EAV) variants during persistent infection in the stallion: origin of the 2007 French EAV outbreak was linked to an EAV strain present in the semen of a persistently infected carrier stallion.. Virology 2012 Feb 20;423(2):165-74.
    pubmed: 22209234doi: 10.1016/j.virol.2011.11.028google scholar: lookup
  63. Molenkamp R, van Tol H, Rozier BCD, van der Meer Y, Spaan WJM, Snijder EJ. The arterivirus replicase is the only viral protein required for genome replication and subgenomic mRNA transcription.. J Gen Virol 2000 Oct;81(Pt 10):2491-2496.
    pubmed: 10993938doi: 10.1099/0022-1317-81-10-2491google scholar: lookup
  64. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.. Methods Enzymol 1987;155:335-50.
    pubmed: 3431465doi: 10.1016/0076-6879(87)55023-6google scholar: lookup
  65. Nugent J, Sinclair R, deVries AA, Eberhardt RY, Castillo-Olivares J, Davis Poynter N, Rottier PJ, Mumford JA. Development and evaluation of ELISA procedures to detect antibodies against the major envelope protein (G(L)) of equine arteritis virus.. J Virol Methods 2000 Nov;90(2):167-83.
    pubmed: 11064117doi: 10.1016/s0166-0934(00)00231-7google scholar: lookup
  66. Pasternak AO, Spaan WJM, Snijder EJ. Nidovirus transcription: how to make sense...?. J Gen Virol 2006 Jun;87(Pt 6):1403-1421.
    pubmed: 16690906doi: 10.1099/vir.0.81611-0google scholar: lookup
  67. Patton JF, Balasuriya UB, Hedges JF, Schweidler TM, Hullinger PJ, MacLachlan NJ. Phylogenetic characterization of a highly attenuated strain of equine arteritis virus from the semen of a persistently infected standardbred stallion.. Arch Virol 1999;144(4):817-27.
    pubmed: 10365172doi: 10.1007/s007050050547google scholar: lookup
  68. Pirzadeh B, Gagnon CA, Dea S. Genomic and antigenic variations of porcine reproductive and respiratory syndrome virus major envelope GP5 glycoprotein.. Can J Vet Res 1998 Jul;62(3):170-7.
    pmc: PMC1189472pubmed: 9684045
  69. Plagemann PG. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.. Virology 2001 Nov 10;290(1):11-20.
    pubmed: 11882995doi: 10.1006/viro.2001.1139google scholar: lookup
  70. Plagemann PG, Chen Z, Li K. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution.. Arch Virol 2001 Jul;146(7):1283-96.
    pubmed: 11556706doi: 10.1007/s007050170091google scholar: lookup
  71. Plagemann PG, Jones QA, Cafruny WA. Polyclonal activation of B cells by lactate dehydrogenase-elevating virus is mediated by N-glycans on the short ectodomain of the primary envelope glycoprotein.. Adv Exp Med Biol 2001;494:375-84.
    pubmed: 11774496doi: 10.1007/978-1-4615-1325-4_56google scholar: lookup
  72. Pronost S, Pitel PH, Miszczak F, Legrand L, Marcillaud-Pitel C, Hamon M, Tapprest J, Balasuriya UB, Freymuth F, Fortier G. Description of the first recorded major occurrence of equine viral arteritis in France.. Equine Vet J 2010 Nov;42(8):713-20.
  73. Racaniello VR, Baltimore D. Cloned poliovirus complementary DNA is infectious in mammalian cells.. Science 1981 Nov 20;214(4523):916-9.
    pubmed: 6272391doi: 10.1126/science.6272391google scholar: lookup
  74. Racaniello VR, Baltimore D. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome.. Proc Natl Acad Sci U S A 1981 Aug;78(8):4887-91.
    pmc: PMC320284pubmed: 6272282doi: 10.1073/pnas.78.8.4887google scholar: lookup
  75. Radwan AI, Burger D. The complement-requiring neutralization of equine arteritis virus by late antisera.. Virology 1973 Jan;51(1):71-7.
    pubmed: 4630828doi: 10.1016/0042-6822(73)90366-8google scholar: lookup
  76. Siddell S.G., Ziebuhr J., Snijder E.J. Coronaviruses, toroviruses and arteriviruses. In: Mahy B.W., ter Meulen V., editors. Topley and Wilsonu05f3s Microbiology and Microbial Infections; Virology Volume. 10th ed. Hodder Arnold; London: 2005. pp. 823u2013856.
  77. Smits SL, Snijder EJ, de Groot RJ. Characterization of a torovirus main proteinase.. J Virol 2006 Apr;80(8):4157-67.
  78. Snijder E, Wassenaar AL, Den Boon JA, Spaan WJ. Proteolytic processing of the arterivirus replicase.. Adv Exp Med Biol 1995;380:443-51.
    pubmed: 8830522doi: 10.1007/978-1-4615-1899-0_71google scholar: lookup
  79. Snijder EJ. The arterivirus replicase. The road from RNA to protein(s), and back again.. Adv Exp Med Biol 1998;440:97-108.
    pubmed: 9782270
  80. Snijder EJ. Arterivirus RNA synthesis dissected. Nucleotides, membranes, amino acids, and a bit of zinc.... Adv Exp Med Biol 2001;494:241-53.
    pubmed: 11774476
  81. Snijder E.J., Spann W.J.M. Arteriviruses. In: Knipe D.M., Howley Peter M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., Straus S.E., editors. Fields Virology. fifth ed. Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2007. pp. 1337u20131355.
  82. Snijder EJ, Kikkert M, Fang Y. Arterivirus molecular biology and pathogenesis.. J Gen Virol 2013 Oct;94(Pt 10):2141-2163.
    pubmed: 23939974doi: 10.1099/vir.0.056341-0google scholar: lookup
  83. Snijder E.J., Kikkert M. Arteriviruses. In: Knipe D.M., Howley P.M., editors. Fields Virology. sixth edition. Walter Kluwar/Lippincott William & Wilson; Philladelphia, PA, USA: 2013.
  84. Snijder E.J., Siddell S.G., Gorbalenya A.E. The Order Nidovirales. In: Mahy W., Meulen V., editors. Topley and Wilsonu05f3s Microbiology and Microbial Infections; Virology Volume. Hodder Arnold; London: 2005. pp. 390u2013404.
  85. Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, Koerten HK, Mommaas AM. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex.. J Virol 2006 Jun;80(12):5927-40.
    pmc: PMC1472606pubmed: 16731931doi: 10.1128/JVI.02501-05google scholar: lookup
  86. Snijder EJ, van Tol H, Pedersen KW, Raamsman MJ, de Vries AA. Identification of a novel structural protein of arteriviruses.. J Virol 1999 Aug;73(8):6335-45.
  87. Snijder EJ, van Tol H, Roos N, Pedersen KW. Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex.. J Gen Virol 2001 May;82(Pt 5):985-994.
    pubmed: 11297673doi: 10.1099/0022-1317-82-5-985google scholar: lookup
  88. Summers-Lawyer K.A., Go Y.Y., Lu Z., Timoney P.J., McCue P.M., Zhang J., Shuck K.M., Bruemmer J. Response of stallions to primary immunization with a modified live equine viral arteritis vaccine. J. Equine Vet. Sci. 2011;31:10.
  89. Tian D, Wei Z, Zevenhoven-Dobbe JC, Liu R, Tong G, Snijder EJ, Yuan S. Arterivirus minor envelope proteins are a major determinant of viral tropism in cell culture.. J Virol 2012 Apr;86(7):3701-12.
    pmc: PMC3302522pubmed: 22258262doi: 10.1128/JVI.06836-11google scholar: lookup
  90. Tijms MA, Nedialkova DD, Zevenhoven-Dobbe JC, Gorbalenya AE, Snijder EJ. Arterivirus subgenomic mRNA synthesis and virion biogenesis depend on the multifunctional nsp1 autoprotease.. J Virol 2007 Oct;81(19):10496-505.
    pmc: PMC2045461pubmed: 17626105doi: 10.1128/JVI.00683-07google scholar: lookup
  91. Tijms MA, Snijder EJ. Equine arteritis virus non-structural protein 1, an essential factor for viral subgenomic mRNA synthesis, interacts with the cellular transcription co-factor p100.. J Gen Virol 2003 Sep;84(Pt 9):2317-2322.
    pubmed: 12917451doi: 10.1099/vir.0.19297-0google scholar: lookup
  92. Tijms MA, van Dinten LC, Gorbalenya AE, Snijder EJ. A zinc finger-containing papain-like protease couples subgenomic mRNA synthesis to genome translation in a positive-stranded RNA virus.. Proc Natl Acad Sci U S A 2001 Feb 13;98(4):1889-94.
    pmc: PMC29352pubmed: 11172046doi: 10.1073/pnas.98.4.1889google scholar: lookup
  93. Timoney P.J. Equine viral arteritis: epidemiology and control. J. Equine Vet. Sci. 1988;8:54u201359.
  94. Timoney P.J., Fallon L., Shuck K., McCollum W.H., Zhang J., Williams N. The outcome of vaccinating five pregnant mares with a commercial equine viral arteritis vaccine. Equine Vet. Educ. 2007;19:6.
  95. Timoney PJ, McCollum WH. Equine viral arteritis.. Vet Clin North Am Equine Pract 1993 Aug;9(2):295-309.
  96. Vairo S, Vandekerckhove A, Steukers L, Glorieux S, Van den Broeck W, Nauwynck H. Clinical and virological outcome of an infection with the Belgian equine arteritis virus strain 08P178.. Vet Microbiol 2012 Jun 15;157(3-4):333-44.
    pubmed: 22306037doi: 10.1016/j.vetmic.2012.01.014google scholar: lookup
  97. van Aken D, Benckhuijsen WE, Drijfhout JW, Wassenaar AL, Gorbalenya AE, Snijder EJ. Expression, purification, and in vitro activity of an arterivirus main proteinase.. Virus Res 2006 Sep;120(1-2):97-106.
  98. van Aken D, Snijder EJ, Gorbalenya AE. Mutagenesis analysis of the nsp4 main proteinase reveals determinants of arterivirus replicase polyprotein autoprocessing.. J Virol 2006 Apr;80(7):3428-37.
  99. Van Breedam W, Delputte PL, Van Gorp H, Misinzo G, Vanderheijden N, Duan X, Nauwynck HJ. Porcine reproductive and respiratory syndrome virus entry into the porcine macrophage.. J Gen Virol 2010 Jul;91(Pt 7):1659-67.
    pubmed: 20410315doi: 10.1099/vir.0.020503-0google scholar: lookup
  100. van den Born E, Posthuma CC, Gultyaev AP, Snijder EJ. Discontinuous subgenomic RNA synthesis in arteriviruses is guided by an RNA hairpin structure located in the genomic leader region.. J Virol 2005 May;79(10):6312-24.
  101. van der Zeijst BA, Horzinek MC. The genome of equine arteritis virus.. Virology 1975 Dec;68(2):418-25.
    pubmed: 173077doi: 10.1016/0042-6822(75)90283-4google scholar: lookup
  102. van Dinten LC, den Boon JA, Wassenaar AL, Spaan WJ, Snijder EJ. An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription.. Proc Natl Acad Sci U S A 1997 Feb 4;94(3):991-6.
    pmc: PMC19627pubmed: 9023370doi: 10.1073/pnas.94.3.991google scholar: lookup
  103. van Dinten LC, Rensen S, Gorbalenya AE, Snijder EJ. Proteolytic processing of the open reading frame 1b-encoded part of arterivirus replicase is mediated by nsp4 serine protease and Is essential for virus replication.. J Virol 1999 Mar;73(3):2027-37.
  104. van Dinten LC, van Tol H, Gorbalenya AE, Snijder EJ. The predicted metal-binding region of the arterivirus helicase protein is involved in subgenomic mRNA synthesis, genome replication, and virion biogenesis.. J Virol 2000 Jun;74(11):5213-23.
  105. van Marle G, Dobbe JC, Gultyaev AP, Luytjes W, Spaan WJ, Snijder EJ. Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences.. Proc Natl Acad Sci U S A 1999 Oct 12;96(21):12056-61.
    pmc: PMC18411pubmed: 10518575doi: 10.1073/pnas.96.21.12056google scholar: lookup
  106. van Marle G, van Dinten LC, Spaan WJ, Luytjes W, Snijder EJ. Characterization of an equine arteritis virus replicase mutant defective in subgenomic mRNA synthesis.. J Virol 1999 Jul;73(7):5274-81.
  107. Weiland E, Bolz S, Weiland F, Herbst W, Raamsman MJ, Rottier PJ, De Vries AA. Monoclonal antibodies directed against conserved epitopes on the nucleocapsid protein and the major envelope glycoprotein of equine arteritis virus.. J Clin Microbiol 2000 Jun;38(6):2065-75.
  108. Zevenhoven-Dobbe JC, Greve S, van Tol H, Spaan WJM, Snijder EJ. Rescue of disabled infectious single-cycle (DISC) equine arteritis virus by using complementing cell lines that express minor structural glycoproteins.. J Gen Virol 2004 Dec;85(Pt 12):3709-3714.
    pubmed: 15557244doi: 10.1099/vir.0.80443-0google scholar: lookup
  109. Zhang J, Go YY, Huang CM, Meade BJ, Lu Z, Snijder EJ, Timoney PJ, Balasuriya UB. Development and characterization of an infectious cDNA clone of the modified live virus vaccine strain of equine arteritis virus.. Clin Vaccine Immunol 2012 Aug;19(8):1312-21.
    pmc: PMC3416077pubmed: 22739697doi: 10.1128/CVI.00302-12google scholar: lookup
  110. Zhang J, Go YY, MacLachlan NJ, Meade BJ, Timoney PJ, Balasuriya UB. Amino acid substitutions in the structural or nonstructural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation.. Virology 2008 Sep 1;378(2):355-62.
    pubmed: 18619638doi: 10.1016/j.virol.2008.06.003google scholar: lookup
  111. Zhang J, Timoney PJ, Maclachlan NJ, Balasuriya UB. Identification of an additional neutralization determinant of equine arteritis virus.. Virus Res 2008 Dec;138(1-2):150-3.
  112. Zhang J, Timoney PJ, MacLachlan NJ, McCollum WH, Balasuriya UB. Persistent equine arteritis virus infection in HeLa cells.. J Virol 2008 Sep;82(17):8456-64.
    pmc: PMC2519626pubmed: 18579588doi: 10.1128/JVI.01249-08google scholar: lookup
  113. Zhang J, Timoney PJ, Shuck KM, Seoul G, Go YY, Lu Z, Powell DG, Meade BJ, Balasuriya UB. Molecular epidemiology and genetic characterization of equine arteritis virus isolates associated with the 2006-2007 multi-state disease occurrence in the USA.. J Gen Virol 2010 Sep;91(Pt 9):2286-301.
    pubmed: 20444993doi: 10.1099/vir.0.019737-0google scholar: lookup

Citations

This article has been cited 2 times.
  1. Moyo NA, Westcott D, Simmonds R, Steinbach F. Equine Arteritis Virus in Monocytic Cells Suppresses Differentiation and Function of Dendritic Cells.. Viruses 2023 Jan 16;15(1).
    doi: 10.3390/v15010255pubmed: 36680295google scholar: lookup
  2. Steinbach F, Westcott DG, McGowan SL, Grierson SS, Frossard JP, Choudhury B. Re-emergence of a genetic outlier strain of equine arteritis virus: Impact on phylogeny.. Virus Res 2015 Apr 16;202:144-50.